SINONASAL SQUAMOUS CELL CARCINOMA
Clinical trials for SINONASAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new SINONASAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for SINONASAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo before surgery may boost sinus cancer outcomes
Disease control Recruiting nowThis study is for people with a type of sinus cancer called sinonasal squamous cell carcinoma. It compares standard chemotherapy before surgery to chemotherapy plus the immunotherapy drug cemiplimab. The goal is to see if adding cemiplimab helps stop the cancer from coming back. …
Matched conditions: SINONASAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 06:23 UTC
-
New combo aims to shrink head and neck tumors, sparing patients from radical surgery
Disease control Recruiting nowThis study tests giving chemotherapy and an immunotherapy drug before standard surgery for head and neck cancer. The goal is to shrink tumors enough so that surgeons can perform a less extensive operation, preserving speech, swallowing, and vision. The trial enrolls 75 adults wit…
Matched conditions: SINONASAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated May 11, 2026 20:49 UTC